An open-label, add-on, drug-drug interaction study to assess the effect of FYX-051 on the pharmacokinetics and safety of warfarin in Japanese healthy adult male

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221293

Enrollment

Registered

2010-11-02

Start date

2010-11-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult male

Interventions

investigational material(s) Generic name etc : FYX-051 INN of investigational material : Therapeutic category code : 394 Agents for treatment of gout Dosage and Administration for Investigational mat

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Japanese healthy adult male

Exclusion criteria

Exclusion criteria: Patients with any disease Subjects with any history of diseases that might affect the assessment in the study Subjects expressing the CYP2C9*3 genotype

Design outcomes

Primary

Measure	Time frame
Pharmacokinetics and Safety	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026